The bladder conditions and urinary symptoms that Elmiron is used to treat can affect both men and women. However, women are more likely to take Elmiron, since females make up 90 percent of patients with IC, according to the University of Rochester Medical Center.
Although patients often develop early symptoms at a younger age, the average age of IC diagnosis is 40. As a result, patients taking Elmiron are often, though not always, 40 or older.